Search
Neuphoria Therapeutics Inc
NEUPAdd to Watchlist
3.550USD
-0.820-18.76%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
19.09MMarket Cap
LossP/E TTM
Neuphoria Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Neuphoria Therapeutics Inc is 8.39, ranking 132 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.45, which is 0.00% below the recent high of -0.45 and -19435.42% above the recent low of -87.81.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.